Avendus bets on this Jhunjhunwala-family backed stock, projects 20% upside

Avendus said that pricing based on outcome and output driven models will drive client relationships and improve long term economic benefits.

Avendus said that pricing based on outcome and output driven models will drive client relationships and improve long term economic benefits.

Gold hit a record $4,383.73 per ounce, fueled by US Federal Reserve rate cuts, safe-haven demand, a weaker dollar, and YES Bank forecasts further gains amid global uncertainty.

Ruby Qc Investment Holdings Pte. Ltd. had a 4.62% stake in Akums Drugs at the end of the September quarter. The firm had invested in the company during its IPO in 2024. The firm is associated with Quadria Capital.

At the upper end of the price band, Gujarat Kidney and Super Speciality is expected to list with a market capitalisation of around ₹899 crore.

The triggers for GMR Airports include a strong project pipeline of new airports — healthy orderbook of aircraft to be delivered and airlines are expecting a sharp growth in domestic and international passenger growth.

38 analysts have coverage on Shriram Finance now, of which 34 have a “buy” rating, three say “hold”, while one has a “sell” rating on the stock. ICICI Securities has the highest price target on the stock on the street…

SEBI is also engaging with the GST Council to resolve GST issues in commodity trading. The SEBI chief said GST hurdles impact the delivery and settlement on the exchange platforms and resolving these issues is key to boost agriculture and…

The US Food and Drug Administration (USFDA) has given its tentative approval for the company’s abbreviated new drug application (ANDA) for Amphetamine Extended-Release Orally Disintegrating Tablets in the 3.1mg, 6.3mg, 9.4mg, 12.5mg, 15.7mg and 18.8mg strengths. It is the generic…

Nomura expects the India business to benefit from an anticipated upcycle, led by Tata Motors CV’s dominant 46% market share in the domestic medium and heavy commercial vehicle segment in FY25.

Twizza is engaged in the manufacturing and distribution of its own branded non alcoholic beverages. Following the acquisition, Twizza will become a step down subsidiary of Varun Beverages.